Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Accumulated Expenses: 2022-2023

Historic Other Accumulated Expenses for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $221,000.

  • Therapeutics' Other Accumulated Expenses fell 53.77% to $221,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $221,000, marking a year-over-year decrease of 53.77%. This contributed to the annual value of $1.4 million for FY2022, which is N/A change from last year.
  • Therapeutics' Other Accumulated Expenses amounted to $221,000 in Q3 2023, which was down 92.78% from $3.1 million recorded in Q2 2023.
  • Therapeutics' 5-year Other Accumulated Expenses high stood at $4.9 million for Q1 2023, and its period low was $179,000 during Q2 2022.
  • Moreover, its 2-year median value for Other Accumulated Expenses was $872,000 (2022), whereas its average is $1.6 million.
  • Over the last 5 years, Therapeutics' Other Accumulated Expenses had its largest YoY gain of 1,611.17% in 2023, and its largest YoY loss of 53.77% in 2023.
  • Over the past 2 years, Therapeutics' Other Accumulated Expenses (Quarterly) stood at $1.4 million in 2022, then slumped by 53.77% to $221,000 in 2023.
  • Its last three reported values are $221,000 in Q3 2023, $3.1 million for Q2 2023, and $4.9 million during Q1 2023.